[go: up one dir, main page]

NO922603L - NEW BENZOMORPHONES AND THEIR USE AS A MEDICINE - Google Patents

NEW BENZOMORPHONES AND THEIR USE AS A MEDICINE

Info

Publication number
NO922603L
NO922603L NO92922603A NO922603A NO922603L NO 922603 L NO922603 L NO 922603L NO 92922603 A NO92922603 A NO 92922603A NO 922603 A NO922603 A NO 922603A NO 922603 L NO922603 L NO 922603L
Authority
NO
Norway
Prior art keywords
alkyl
new
benzomorphones
medicine
acyl
Prior art date
Application number
NO92922603A
Other languages
Norwegian (no)
Other versions
NO178263B (en
NO178263C (en
NO922603D0 (en
Inventor
Adrian Carter
Helmut Ensinger
Matthias Grauert
Franz Joseph Kuhn
Herbert Merz
Enzio Mueller
Werner Stransky
Ilse Streller
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO922603D0 publication Critical patent/NO922603D0/en
Publication of NO922603L publication Critical patent/NO922603L/en
Publication of NO178263B publication Critical patent/NO178263B/en
Publication of NO178263C publication Critical patent/NO178263C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Benzomorphane derivs. of formula (I) are new. In (I), X = O or S; R1 = 1-8C alkyl, 3-6C alkenyl, 3-6C alkynyl or aryl; R2 = H, 1-8C alkyl, 3-6C alkenyl, 3-6C alkynyl, aryl or aralkyl; R3 = H or 1-6C alkyl; R4 and R5 = each 1-8C alkyl; R6 = 1-8C alkyl or aryl; R7 and R8 = each H, 1-8C alkyl, halogen, OH, 1-8C alkoxy, O-Acyl, CN, NO2, NH2, NH(1-8C alkyl), N(1-8C alkyl)2 (n which the alkyl gps. are opt. different), NH-acyl or N-acyl-(1-8C alkyl).
NO922603A 1991-07-02 1992-07-01 New benzomorphans and their use as a drug NO178263C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4121821A DE4121821A1 (en) 1991-07-02 1991-07-02 NEW BENZOMORPHANE AND ITS USE AS A MEDICAMENT

Publications (4)

Publication Number Publication Date
NO922603D0 NO922603D0 (en) 1992-07-01
NO922603L true NO922603L (en) 1993-01-04
NO178263B NO178263B (en) 1995-11-13
NO178263C NO178263C (en) 1996-02-21

Family

ID=6435223

Family Applications (1)

Application Number Title Priority Date Filing Date
NO922603A NO178263C (en) 1991-07-02 1992-07-01 New benzomorphans and their use as a drug

Country Status (24)

Country Link
EP (1) EP0521422B1 (en)
JP (1) JP3324785B2 (en)
KR (1) KR100251256B1 (en)
AT (1) ATE137749T1 (en)
AU (1) AU657330B2 (en)
CA (1) CA2072814C (en)
CZ (1) CZ286949B6 (en)
DE (2) DE4121821A1 (en)
DK (1) DK0521422T3 (en)
ES (1) ES2086585T3 (en)
FI (1) FI105913B (en)
GR (1) GR3020124T3 (en)
HK (1) HK1003111A1 (en)
HU (1) HU220873B1 (en)
IE (1) IE74400B1 (en)
IL (1) IL102361A (en)
MX (1) MX9203845A (en)
NO (1) NO178263C (en)
NZ (1) NZ243388A (en)
PH (1) PH31430A (en)
SG (1) SG43001A1 (en)
SK (1) SK280776B6 (en)
TW (1) TW214547B (en)
ZA (1) ZA924883B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528472A1 (en) * 1995-08-03 1997-02-06 Boehringer Ingelheim Kg New process for the production of norbenzomorphan of an intermediate stage in the production of pharmaceutically valuable benzomorphan derivatives, in particular of (-) - (1R, 5S, S "R) -3'-hydroxy-2- (2-methoxypropyl -) - 5.9.9 -trimethyl-6.7 benzomorphan
DE19740110A1 (en) 1997-09-12 1999-03-18 Boehringer Ingelheim Pharma Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, process for their preparation and their use as medicaments
JPH1196519A (en) * 1997-09-17 1999-04-09 Alps Electric Co Ltd Spin valve type thin-film element and its production
US6136980A (en) * 1998-05-01 2000-10-24 Boehringer Ingelheim Kg Method of preparing norbenzomorphane as an intermediate in the preparation of pharmaceutically useful benzomorphane derivatives, in particular (-)-(1R,5S,2"R)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzo morphane
DE19826365A1 (en) * 1998-06-12 1999-12-16 Gruenenthal Gmbh Use of benzomorphan derivatives as an analgesic
US6355652B1 (en) 1999-11-27 2002-03-12 Boehringer Ingelheim Pharma Kg Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions
DE19957156A1 (en) * 1999-11-27 2001-05-31 Boehringer Ingelheim Pharma New amino and fluoro substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine derivatives useful in treatment of e.g. arrythmias, spasms, ischaemia, pain and neurodegenerative disorders
DE10204276A1 (en) * 2002-02-02 2003-08-07 Boehringer Ingelheim Pharma N-Allyloxyethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceuticals
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP1506174B1 (en) 2002-05-17 2015-09-30 Taiwanj Pharmaceuticals Co., Ltd. Use of naltrexone for treating kidney and liver damage
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8859580B2 (en) * 2007-11-16 2014-10-14 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
US9862726B2 (en) 2013-12-26 2018-01-09 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7804509A (en) * 1978-04-26 1979-10-30 Acf Chemiefarma Nv Novel 6,7-benzomorphan derivatives and their acid addition salts.
DE2828039A1 (en) * 1978-06-26 1980-01-10 Boehringer Sohn Ingelheim 2- (2-ALKOXYETHYL) -2'-HYDROXY-6,7-BENZOMORPHANES THEIR ACID ADDITION SALTS, THESE MEDICINAL PRODUCTS, AND METHOD FOR THE PRODUCTION THEREOF
NL7907800A (en) * 1979-10-23 1981-04-27 Acf Chemiefarma Nv Novel 6,7-benzomorphan derivatives and their acid addition salts, pharmaceutical compositions containing such a compound, and process for the preparation of these compounds and their pharmaceutical compositions.

Also Published As

Publication number Publication date
HU220873B1 (en) 2002-06-29
NO178263B (en) 1995-11-13
DE4121821A1 (en) 1993-01-14
IE74400B1 (en) 1997-07-30
IL102361A0 (en) 1993-01-14
JP3324785B2 (en) 2002-09-17
HK1003111A1 (en) 1998-10-09
SK207592A3 (en) 1997-01-08
EP0521422B1 (en) 1996-05-08
KR930002321A (en) 1993-02-22
FI923050A0 (en) 1992-07-01
HU9202199D0 (en) 1992-10-28
DE59206212D1 (en) 1996-06-13
PH31430A (en) 1998-11-03
NO178263C (en) 1996-02-21
ES2086585T3 (en) 1996-07-01
IL102361A (en) 1997-02-18
CZ207592A3 (en) 1993-08-11
CZ286949B6 (en) 2000-08-16
NZ243388A (en) 1994-11-25
SK280776B6 (en) 2000-07-11
FI105913B (en) 2000-10-31
ZA924883B (en) 1993-02-24
NO922603D0 (en) 1992-07-01
IE922144A1 (en) 1993-01-13
KR100251256B1 (en) 2000-05-01
TW214547B (en) 1993-10-11
CA2072814C (en) 2003-09-23
AU657330B2 (en) 1995-03-09
DK0521422T3 (en) 1996-06-10
FI923050A (en) 1993-01-03
ATE137749T1 (en) 1996-05-15
MX9203845A (en) 1993-01-01
JPH05201987A (en) 1993-08-10
GR3020124T3 (en) 1996-08-31
SG43001A1 (en) 1997-10-17
CA2072814A1 (en) 1993-01-03
AU1868692A (en) 1993-01-07
HUT66410A (en) 1994-11-28
EP0521422A1 (en) 1993-01-07

Similar Documents

Publication Publication Date Title
NO922603D0 (en) NEW BENZOMORPHONES AND THEIR USE AS A MEDICINE
PA8510101A1 (en) ANTIBACTERIAL AGENTS OF 3-AMINOQUINAZOLIN-2,4 DIONAS.
LU92545I2 (en) Ezetimibe in combination with atorvastatin or their pharmaceutically acceptable salts, including atorvastatin in the form of atorvastatin calcium trihydrate
HUP0003731A2 (en) 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
DE69420564D1 (en) IMMUNEUPPRESSIVE AND ANTIALLERGIC COMPOUNDS; E.g. N- (3-OXOHEXANOYL) HOMOSERINLACTONE
DK0920421T3 (en) Isoxazoline derivatives useful as antimicrobial agents
ES2180633T3 (en) USE OF PTERIDINE DERIVATIVES AS INHIBITORS OF NON-SYNTHEASE.
NO912940D0 (en) IMMUNE REPRESENTATIVE AGENT AND PROCEDURE FOR PREPARING THE SAME.
DK0671156T3 (en) Cosmetic or pharmaceutical preparations containing liposomes
NO933425L (en) NEW ACTIVE RELATIONSHIPS
YU12992A (en) 2-AMINO-1,2,3,4, -TETRAHYDRONAPHTHALENE SUBSTITUTED IN THE RING
DK0722319T3 (en) Anthracycline derivatives and their use in amyloidosis
LV11817A (en) Arylalkylamines and amides with anticonvulsants and neuroprotectives
TW333532B (en) Benzopyrans
ES2158809A1 (en) New phenylsulfonate compounds are cyclooxygenase II inhibitors used for treating e.g. inflammation and Alzheimer's disease

Legal Events

Date Code Title Description
MK1K Patent expired